Clostridium butyricum for anxiety and depression in functional dyspepsia
Official title: Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Run by Xijing Hospital of Digestive Diseases · NCT07182890 · Data updated 2026-11-12
This trial will test whether taking the probiotic Clostridium butyricum for four weeks can reduce anxiety and depression symptoms in adults with functional dyspepsia.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Xijing Hospital of Digestive Diseases Academic / other |
| Locations | 1 site (Xi’an, Shanxi) |
| Status | Recruiting |
| Started | March 26, 2026 |
| Main results expected | October 30, 2026 |
| Study ends | May 31, 2027 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT07182890 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with Rome IV–diagnosed functional dyspepsia and HADS scores of 8–14 who are not pregnant, are H. pylori–negative, and have not used probiotics, antibiotics, or psychoactive medications in the prior month.
✕Probably not a fit
Patients with severe mood disorders (HADS outside 8–14), positive H. pylori, recent antibiotic or probiotic use, ongoing psychoactive medication, major comorbid GI disorders, pregnancy, or a history of substance abuse are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind Phase 4 trial will enroll 180 adults with functional dyspepsia (90 per group) who have mild-to-moderate anxiety or depression (HADS 8–14). All participants will continue conventional FD treatment while one group receives oral Clostridium butyricum and the other receives a matched placebo for four weeks. The primary outcome is change in Hospital Anxiety and Depression Scale (HADS) score after four weeks, with secondary outcomes likely including symptom and safety measures. The design excludes recent probiotic/antibiotic use, recent psychoactive medication, and H. pylori–positive patients to isolate the probiotic's effect on mood symptoms.
Why it matters
Potential benefit: If effective, the probiotic could offer a low-risk adjunct to standard FD care that reduces anxiety and depression symptoms.
How similar studies have gone: Prior probiotic studies and early research on gut–brain interactions have shown mixed but sometimes modest improvements in mood, while evidence specifically for Clostridium butyricum in this context is limited and preliminary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with functional dyspepsia (FD) according to the Rome IV criteria. * Aged 18 to 80 years, regardless of gender. * Hospital Anxiety and Depression Scale (HADS) score between 8 and 14. Exclusion Criteria: * Use of probiotics or antibiotics within one month prior to the trial. * Use of psychoactive medications (including hypnotics, sedatives, anxiolytics, or antidepressants) within one month prior to the trial. * Use of hormones, immunosuppressants, or cytotoxic agents within one month prior to the trial. * Participation in any other clinical trial within one month prior to the study. * Positive test for Helicobacter pylori (Hp) infection. * Long-term use of traditional Chinese herbal medicine. * Pregnancy or lactation. * History of drug abuse. * Comorbidities such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), functional constipation (FC), or other significant conditions that may interfere with the trial-including severe hepatic, renal, respiratory, or autoimmune disorders; bleeding diatheses; psychiatric diseases; endocrine disorders; etc. * History of major surgery or diagnosis of diabetes mellitus. * Refusal to provide written informed consent.
Where it's running
-
Air Force Medical University
Xi’an, Shanxi, China Recruiting
Study contacts
- Study coordinator: Yongquan Shi Shi
- Email: shiyquan@fmmu.edu.cn
- Phone: 029-84771515
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
-
An Ultra-Brief ICBT Intervention with Personal Feedback for Depression and Anxiety
This trial tests whether adding personalized feedback about a person’s recent healthy actions to the Things You Do ultra-brief online CBT program helps adults with depression and anxiety do more healthy activities and feel better.
-
Virtual nature vs guided imagery for anxiety and well-being in hospitalized older adults
In this study, hospitalized adults 65 and older try two ways to bring nature to them: watching 360-degree nature videos on a VR headset or listening to a guided imagery audio to imagine the same scenes, to see which helps mood and anxiety during a two-week period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.